Podcasts about Clinical

In this throwback episode of Very Clinical, Zach and Kevin welcome back Charlie Fryer to talk about AI in dentistry. Charlie recently finished a master's thesis about class II caries and AI so he can see applications in dentistry from the perspective of a computer scientist. AI's Current Role in the Dental Industry The guys discuss existing and potential applications of Artificial Intelligence (AI) in dentistry, acknowledging that the future of the profession will be heavily influenced by this technology. Invisalign/Aligners: Kevin notes that companies like Align Technology (Invisalign) are essentially data companies that leverage millions of intraoral scans from iTero to perfect tooth-movement algorithms and quickly generate treatment plans. He suspects much of the initial clin-check setup is AI-driven, with human checks afterward. Design & Manufacturing: AI is already used for the automated design and quick file return for appliances like night guards by companies like SprintRay, as well as for crown design in some printing workflows. Radiographic Diagnosis: The hosts discuss companies that use AI to read and assist in diagnosing findings on X-rays. A key discussion point is how these companies, like DSOs (Dental Service Organizations) such as Heartland or Aspen, acquire the vast amounts of patient data needed to train their models. The hosts posit that users become the "product," providing data with every image analyzed. Future AI Applications and Benefits The conversation shifts to more future-facing applications and the overall impact of AI on dental practice. Net Positive Impact: Zach and Kevin agree that AI will be a net positive for dentistry, primarily as an aid rather than a replacement for clinical judgment, drawing an analogy to how a GPS system advises a driver but the driver still makes the final decisions. Combining Data Sets: Charlie suggests combining various patient data, such as cone beam CTs, intraoral scans, and radiographic images, to develop next-generation tools for complex procedures like implant placement guidance. Practice Optimization: A major area for AI development is practice management. They discuss using machine learning to: Optimize scheduling based on patient history (recurrent neural networks) and procedure mix to maximize profitability and account for unexpected needs. Forecast inventory needs to ensure the practice is always adequately stocked. Financial and Marketing Tools: Patient Financing: Kevin highlights Sun Bit, a payment program that uses an AI component to quickly determine a patient's payment risk and rate by analyzing non-traditional data like utility payments instead of a full credit report. Marketing: AI is already effective in predicting click-through rates for online advertisements, which could be leveraged by dental practices. Join the Very Clinical Facebook group!  Join the Very Dental Facebook group using the password "Timmerman," Hornbrook" or "McWethy," "Papa Randy," "Lipscomb" or "Gary!" The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! -- Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code “VERYDENTAL10” you'll get another 10% off your order! Go save yourself some money and support the show all at the same time! -- The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! -- Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! -- CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!  

This episode of KeyLIME+ delves into the complexities of clinical learning environments in medical education. Adam and guest co-host Danielle Chang speak with Jena Hall about the dynamic nature of these environments, their impact on patient outcomes, and the importance of adapting to external societal influences. They discuss the challenges of physician burnout, the role of social media, and the integration of AI in medical training. The conversation emphasizes the need for intentional adaptability in educational practices to foster a supportive and effective learning atmosphere for the doctors of tomorrow.    Length of episode : 39:45    Resources to check out:   Nordquist J, Silva S, Caverzagie K, Hall J. Clinical learning environments: Updates. Med Teach. 2025 Jun;47(6):911-917. https://pubmed.ncbi.nlm.nih.gov/39901697/      Asch DA, Nicholson S, Srinivas S, et al. Evaluating obstetrical residency programs using patient outcomes. JAMA. 2009;302(12):1277–1283. doi: 10.1001/jama.2009.1356    Thoma B, Karwowska A, Samson L, Labine N, Waters H, Giuliani M, Chan TM, Atkinson A, Constantin E, Hall AK, Gomez-Garibello C, Fowler N, Tourian L, Frank J, Anderson R, Snell L, Van Melle E. Emerging concepts in the CanMEDS physician competency framework. Can Med Educ J. 2023 Mar 21;14(1):4-12. https://pubmed.ncbi.nlm.nih.gov/36998506/     Contact us: keylime@royalcollege.ca      Follow: Dr. Adam Szulewski https://x.com/Adam_Szulewski    

If you've been looking for a way to add consistent revenue to your practice without selling more supplements or adding more appointments, this episode is for you. We're talking about creating a non-clinical product bundle using everyday items your patients already use and love, like toothpaste, shampoo, barrier creams, or non-toxic cleaners. Only this time, you're the trusted source, not Amazon or Target. In this episode, you'll learn: ✔️ What to include in a non-clinical monthly or seasonal bundle ✔️ How to theme, price, and package it simply ✔️ Easy fulfillment options (no tech headaches required) ✔️ Messaging that builds trust and retention, not pressure

A new startup in Minnesota's medical technology hub recently won an annual statewide business competition. Twin Cities based AcQumen Medical walked away from this year's MN Cup with $100,000 in prizes. Its winning idea is a device to measure blood flow in babies who are in neonatal intensive care. Clinical trials for the device will begin later this week. AcQumen Medical co-founder and CEO Dori Jones joined MPR News host Nina Moini to talk about it.

271: Clinical pharmacist Dr. John Kim was just 33 years old when a heart attack changed everything he thought he knew about practicing medicine. Today, he's one of the top functional medicine doctors - and he's been helping me with my personal detox journey. In part one of two, Dr. Kim joins me to share the truth about cholesterol, prescription medication, and mold.  Topics Discussed: → Why did Dr. John Kim have a heart attack at age 33? → What are the biggest misconceptions about cholesterol and statins? → Is fish oil actually bad for you? → How does mold exposure affect your health? → What are the best ways to detox from mold naturally?  Sponsored By: → Beekeepers Naturals | Go to www.beekeepersnaturals.com/REALFOODOLOGY or enter code REALFOODOLOGY to get 20% off your order. → Timeline | Timeline is offering 10% off your order of Mitopure Go to www.timeline.com/REALFOODOLOGY. → Manukora | Go to www.manukora.com/REALFOODOLOGY to get $25 off the Starter Kit, which comes with an MGO 850+ Manuka Honey jar, 5 honey travel sticks, a wooden spoon, and a guidebook! → BIOptimizers | For 15% off go to www.bioptimizers.com/realfoodology and use promo code REALFOODOLOGY. → Our Place | Visit www.fromourplace.com/REALFOODOLOGY and use code REALFOODOLOGY for 10% off sitewide. → Vimergy | New customers can save 20% off their first order with the code REALFOODOLOGY at www.vimergy.com.  Timestamps:  → 00:00:00 - Introduction → 00:05:24 - Dr Kim's Heart Attack at 33  → 00:12:18 - Cholesterol + Statins: Misconceptions  → 00:20:29 - Lifestyle vs. Medication   → 00:24:03 - Quality Concerns: Fish Oil + Supplements   → 00:31:03 - Mold, Lyme, & Microtoxins   → 00:42:55 - Building Cellular Resilience  → 00:52:03 - Supporting Local Farms  → 00:56:38 - Mold Detox Tips   Show Links: → Kim Wellness  Check Out: → Dr. John Kim  Check Out Courtney:  →  LEAVE US A VOICE MESSAGE →  Check Out My new FREE Grocery Guide! →  @realfoodology →  www.realfoodology.com →  My Immune Supplement by 2x4 →  Air Dr Air Purifier →  AquaTru Water Filter →  EWG Tap Water Database Produced By: Drake Peterson

In Session 313, Dr. Cody Morris from Salve Regina University, and the newly re-launched All Things Behavior podcast (please also see The BAPcast Podcast), joins me to dive into a topic that has merited quite a bit of discussion in Applied Behavior Analysis. These days, you pretty much have to be living under a rock in ABA circles to not have noticed the increased focus on assent practices in treatment programming. Cody is one of the preeminent authorities on this topic, and in this episode, we talk about the definitions of assent, how assent has been conceptualized in other fields, and how it applies to the work we do as Behavior Analysts. In doing so, we review Cody's article, Toward a Further Understanding of Assent, which was published in the winter 2024 issue. Long story short, if you're looking for a nuanced discussion on this topic that avoids binary, black and white conceptualizations, you've come to the right place. Here's a deeper dive into what we discussed: Assent in Behavior Analysis: Cody's research on assent—a concept similar to consent but applicable to individuals without legal authorization to consent for themselves. Assent involves four critical features: legal status, giving permission, adequate information, and the ability to withdraw permission. This concept is essential for involving clients in therapeutic decisions, particularly those with communication differences or developmental disabilities. Client Assent in Therapeutic Settings: The discussion covers the historical roots and practical applications of assent in behavior analysis. Cody clarifies that assent is a specific strategy for involving clients in treatment decisions, not an all-or-nothing requirement. He addresses the challenges of obtaining accurate verbal assent from clients with complex communication needs and recommends using multiple sources of information when assessing client preferences. Assent Procedures in Research: An examination of assent procedures in behavior analytic research, including the distinction between free choice and fair choice. The episode explores how researchers and clinicians can minimize undue influence and coercive contingencies while arranging fair choices and creating socially acceptable outcomes. Balancing Clinical Progress and Client Autonomy: Cody discusses the critical balance between making clinical progress and giving clients independence and autonomy. He explains that while some procedures are necessary and non-negotiable, there are often opportunities to involve clients in decisions about their treatment, such as choosing the time of day or setting for therapeutic activities or medication management. Implementing Assent in Practice: The episode addresses nuances and limitations of implementing client assent in behavioral therapy, emphasizing that assent should be balanced with clinical progress. Cody highlights the dangers of overgeneralizing procedures without individualizing treatment and encourages a broader approach to maximizing client involvement in therapeutic decisions. Challenges in Assent Assessment: A discussion on the challenges and limitations of developing simplified decision-making tools (like checklists) for assessing client assent. Cody emphasizes the need for nuanced clinical judgment due to insufficient research and recommends that researchers take small, focused steps in studying specific aspects of assent. Resources & References Morris, Dietrich, and Peterson. (2021). Participant assent in behavior analytic research: Considerations for participants with autism and developmental disabilities. Bannerman, et al., (1990). Balancing the right to habilitation with the right to personal liberties: The rights of people with developmental disabilities to eat too many doughnuts and take a nap. Inside JABA 24: Improving Health Routines for Adults with Disabilities Using Synchronous Reinforcement Strategies (CEU available!). Inside JABA 23: ABA Strategies for Safer Playground Behavior (CEU available!). Inside JABA 22: Response to Name Interventions for Staff and Caregivers (CEU available!). Skinner (1999). Cumulative Record. Northup (2000). Further evaluation of the accuracy of reinforcer surveys: A systematic replication. Good Will Hunting. Takeaways for Practitioners Assent is one tool within a larger framework of client-centered services, not the sole focus of treatment Incorporate clients in as many meaningful decisions as possible throughout treatment, distinguishing between necessary procedures and flexible choices Use multiple sources of information when assessing client preferences, especially for individuals with complex communication needs Balance clinical progress with client autonomy and independence Avoid overgeneralizing or rigidly following assent procedures without individualizing treatment Take a nuanced, clinically-informed approach to client involvement in therapeutic decisions This episode is brought to you by the following sponsors: •    Frontera. Consider taking a demo of Frontera's Assessment Builder and see how the ethical application of AI technologies can help you serve clients and save you time! Your first assessment report is free. And if you use code BOP25 you'll get an additional five assessments for just $100. So head to fronterahealth.com to check it out! •    MindBodyBehavior's Certified Health Coach Program. If you're a BCBA looking to use your ABA skills to help people live healthier lifestyles, learn how to do it the right way, with expert instruction, mentoring, and guidance from Sarah Burby. Better still, podcast listeners can save $$$ by using the code BOP10 at check out. Click here to learn more! •    HRIC Recruting. Cut out the middleman and speak directly with Barbara Voss, who's been placing BCBAs in great jobs all across the US for 15 years. •    Behavior University. Their mission is to provide university quality professional development for the busy Behavior Analyst. Learn about their CEU offerings, including their 8-hour Supervision Course, as well as their RBT offerings over at behavioruniversity.com/observations. Don't forget to use the coupon code, PODCAST to save at checkout! •    The 2026 Verbal Behavior Conference! Taking place March 26–27, 2026, in Austin, Texas, or livestream and on-demand on BehaviorLive. Presenters will include Drs. Mark Sundberg, Patrick McGreevy, Caio Miguel, Alice Shillingsburg, Sarah Frampton, Andresa De Souza, and Danielle LaFrance will share how Skinner's analysis of verbal behavior can guide the assessment and treatment of generative learning challenges in children with autism and other developmental disabilities. And don't miss the special pre-conference workshop on Wednesday, March 25, led by Dr. Emily Kerwin and Gina Zecchin-Tirri from All Points Behavior (formerly The Carbone Clinic). The discounted early-bird registration price is only available for a limited time, so get your ticket right away!

Clinical trials pave the way for new breast cancer treatments, but many patients hesitate to take part. Dr. Elkhanany breaks down what these studies really mean and why access and education make a difference. What clinical trials are and how they work for patients Why every standard medicine starts with a trial How learning and access change treatment for everyone Key Questions Answered What is a clinical trial? Why do we need clinical trials? How do clinical trials progress from phase one to phase four? Why is it often difficult to get people to participate in clinical trials? How do you address patient skepticism towards clinical trials? Who decides if a new drug’s benefit is worth its risks? How do drug approval processes in the United States differ from those in Europe? What are the potential benefits for patients who participate in clinical trials? How do you approach a patient when recommending a clinical trial, especially if standard treatments have failed? What support systems exist to help patients participate in clinical trials, especially those traveling long distances or facing financial barriers? Timestamped Overview 00:00 Understanding Clinical Trials Stages 06:10 Advancing Medicine Through Clinical Trials 07:49 Cancer Treatment Decision Challenges 12:03 Global Drug Trial Decision Process 16:31 Immunotherapy Breakthrough in Cancer Treatment 20:10 Clinical Trials: Challenges and Importance 23:52 Key Patient Advice: Second Opinions 26:01 Bridging Clinical Trial Accessibility 29:05 Advancements Reducing Breast Cancer Mortality Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Clinical trials pave the way for new breast cancer treatments, but many patients hesitate to take part. Dr. Ahmed Elkhanany returns to the show to break down what these studies really mean and why access and education make a difference. What clinical trials are and how they work for patients Why every standard medicine starts with a trial How learning and access change treatment for everyone Key Questions Answered What is a clinical trial? Why do we need clinical trials? How do clinical trials progress from phase one to phase four? Why is it often difficult to get people to participate in clinical trials? How do you address patient skepticism towards clinical trials? Who decides if a new drug’s benefit is worth its risks? How do drug approval processes in the United States differ from those in Europe? What are the potential benefits for patients who participate in clinical trials? How do you approach a patient when recommending a clinical trial, especially if standard treatments have failed? What support systems exist to help patients participate in clinical trials, especially those traveling long distances or facing financial barriers? Timestamped Overview 00:00 Understanding Clinical Trials Stages 06:10 Advancing Medicine Through Clinical Trials 07:49 Cancer Treatment Decision Challenges 12:03 Global Drug Trial Decision Process 16:31 Immunotherapy Breakthrough in Cancer Treatment 20:10 Clinical Trials: Challenges and Importance 23:52 Key Patient Advice: Second Opinions 26:01 Bridging Clinical Trial Accessibility 29:05 Advancements Reducing Breast Cancer Mortality Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts.See omnystudio.com/listener for privacy information.

Send us a textKeeping up to date in the world of hair loss Who better to finish this season but the legendary Dr Jeff Donovan!Dr Donovan is from British Colombia in Canada. During his training, he became fascinated by the number of skin disorders there are, and wanted to specialise in this. With over 2,000 types of skin disease, he enjoys the diagnostic skills that go into investigating these!He loves to help people get back to 'normal', and we discuss how hair loss can often take something away from a person. We explore how to best keep up to date with the ever evolving field of trichology, current literature and studies. Dr Donovan also shares how laboratory investigations differ in different regions, and why this might be.I also discover the benefits of looking for updates in other fields, when the discussion turns to how some medications can be harmful to pets.Connect with Dr Donovan:InstagramThreadsEvidence Based Hair FellowshipCOLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialistshttps://onlinelibrary.wiley.com/doi/full/10.1002/jvc2.70067Minoxidil toxicosis in cats and dogs: A scoping review and call to actionhttps://www.sciencedirect.com/science/article/pii/S019096222500595X Hair & Scalp Salon Specialist course Support the showConnect with Hair therapy: Facebook Instagram Twitter Clubhouse- @Hair.Therapy Donate towards the podcast Start your own podcastHair & Scalp Salon Specialist Course ~ Book now to become an expert!

Clinical psychologist, Dr. Sarah Adler, joins the show this week to talk about why “AI Therapy” doesn't exist, but is bullish on what AI can help therapists achieve.Dr. Adler is a clinical psychologist and CEO of Wave. She's building AI tools for mental healthcare, which makes her position clear—what's being sold as "AI therapy" right now is dangerous.Chatbots are optimized to keep conversations going. Therapy is designed to build skills within bounded timeframes. Engagement is not therapy. Instead, Dr. Adler sees AI as a powerful recommendation engine and measurement tool, not as a therapist.George K and George A talk to Dr. Adler about what Ethical AI looks like, the model architecture for personalized care, who bears responsibility and liability, and more.The goal isn't replacing human therapists. It's precision routing—matching people to the right care pathway at the right time. But proving this works requires years of rigorous study. Controlled trials, multiple populations, long-term tracking. That research hasn't been done.Dr. Adler also provides considerations and litmus tests you can use to discern snake oil from real care.Mental healthcare needs innovation. But you cannot move fast and break things when it comes to human lives.Mentioned:A Theory of Zoom FatigueKashmir Hill's detailed reporting on Adam Raine's death and the part played by ChatGPT (Warning: detailed discussion of suicide)Colorado parents sue Character AI over daughter's suicideSewell Setzer's parents sue Character AIDeloitte to pay money back after caught using AI in $440,000 report

Clinical psychologist Dr. Dana Harron joins me to discuss how couples can approach difficult conversations about eating disorders with honesty, care, and mutual respect. Together we explore what makes these conversations emotionally charged, how to prepare for them, and how partners can support each other without taking on the role of therapist or monitor. Dr. Harron offers practical guidance from her book Loving Someone With an Eating Disorder and her work at Monarch Wellness & Psychotherapy. You'll learn what helps these conversations go more smoothly, how to create safety before and after hard talks, and when to bring in a therapist who understands both eating disorders and couples dynamics. Content Caution This episode discusses eating disorders, disordered eating behaviors, and relationship stress that can arise during recovery. Some listeners may find certain details activating. Please take care of yourself while listening, and pause or skip ahead as needed. About Our Guest Dana Harron, PsyD is a clinical psychologist and founder of Monarch Wellness & Psychotherapy in Washington, D.C. She specializes in trauma, parenting, and eating disorders. She is the author of Loving Someone With an Eating Disorder: Supporting, Nurturing, and Connecting With Your Partner and is currently writing Parenting Beyond Trauma. You can find her work at monarchwellness.com and on Instagram at @monarchwellnesspsychotherapy. What You'll Learn How to prepare before opening up about your eating disorder to a partner Why I-statements and emotional honesty matter more than having all the answers The best times and places for difficult conversations about food and body image What to say when your partner asks questions you cannot answer yet How to plan a follow-up discussion and build routine check-ins Why post-conversation decompression helps the nervous system reset What couples therapy can look like when one partner struggles with an eating disorder How to balance support and autonomy without creating a power differential Conversation Highlights Dr. Harron shares how her book was inspired by the lack of resources for partners of adults with eating disorders. Tips for partners on when to speak, when to listen, and how to avoid meal-time conversations about food behaviors. The importance of humor, co-regulation, and small moments of levity in recovery. How systemic patterns in relationships can reinforce eating disorder behaviors. Why “honesty” in recovery is about emotional congruence, not just full disclosure. Key Takeaways for Couples Prime the moment: Let your partner know a sensitive topic is coming and ask for what you need—listening, reassurance, or space. Avoid high-stress times: Skip conversations around meals or when one partner is emotionally depleted. Plan ongoing conversations: Short, consistent check-ins build predictability and reduce tension. Use shared recovery language: I-statements and gentle curiosity create safety and understanding. Involve professionals: A therapist or dietitian trained in eating disorders can guide communication and prevent relational burnout. Related Episodes You're Not Too Much: Setting Boundaries & Asking for What You Need in Eating Disorder Recovery on Apple & Spotify. "Boundaries, Therapy While Black, & Eating Disorders" on Apple & Spotify Work With Dr. Marianne If you or your partner are navigating eating disorder recovery and want support that honors both of your needs, I offer therapy in California, Texas, and Washington, D.C., and global coaching for couples and individuals. My approach is neurodivergent-affirming, sensory-attuned, trauma-informed, and consent-based. Learn more or schedule a consultation at drmariannemiller.com. Learn With Me Explore my ARFID & Selective Eating Course to understand sensory challenges, reduce distress around meals, and improve communication within your household. Episode Credits Host: Dr. Marianne Miller, LMFT Guest: Dr. Dana Harron, Monarch Wellness & Psychotherapy (@monarchwellnesspsychotherapy) If this episode resonates, share it with a partner, therapist, or loved one who may benefit from a more compassionate way to talk about eating disorders and recovery.

Learn more about Brodie's Research Database & AI Assistant

In his weekly clinical update, Dr. Griffin with Vincent Racaniello chat about Jane Goodall's death and the Nobel prize in Physiology/Medicine for understanding immune system control before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, if 2 doses of the influenza vaccine are better for protection of first season children, if COVID-19 negatively impacts pregnancy and the unborn child, efficacy of long-acting monoclonal antibody against symptomatic COVID-19, where to find PEMGARDA, how to access and pay for Paxlovid, can you be retreated with Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, long COVID in pediatrics, association of COVID-19 with new-onset vascular dementia and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Jane Goodall's legacy: three ways she changed science (Nature) They understood how the immune system is kept in check (The Nobel Prize) Daniel Griffin: The Nobel Prize for Understanding Autoimmune Disease (WNYC: New York Public Radio) Kennedy's Ties to Ally Leading Vaccine Lawsuits Raise Ethical Concerns (NY Times) Ebola outbreak in southern Congo shows signs of containment with no new cases, WHO reports (AP News) Ebola Disease (WHO: African Region) Premature baby dies from measles in Alberta as cases throughout province near 2,000(Global News) DOH Issues Advisory After Measles Detection in City of Oswego Wastewater (Finger lakes dailynew.com) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Influenza-Associated Pediatric Deaths — United States, 2024–25 Influenza Season (CDC: MMWR) ACIP Recommendations Summary (CDC: Influenza) American Academy of Pediatrics Flu and Children (CDC: Influenza (flu)) Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza (JAMA: Open Network) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines(Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Neonatal outcomes among pregnant women with COVID-19 (BMC Pregnancy and Childbirth) Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19 (CID) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity (CID) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR) (LANCET: Infectious Diseases) Prevalence and duration of clinical symptoms of pediatric long COVID (Frontiers in Pediatrics) COVID-19 infection associated with increased risk of new-onset vascular dementia in adults ≥50 years(NPJ| dementia) Reaching out to US house representative Letters read on TWiV 1260 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Like Hippocrates said, “All Disease Begins in the Gut.” Here in functional/personalized medicine, stool testing is an important tool to help get to the root cause of chronic conditions or to optimize health. Given its vital role in clinical practice, choosing the right stool test becomes paramount and being mindful of the information you are seeking is key. In today’s episode, we're taking the conversation deeper, refocusing on why studying the microbiome is so critical. This episode redefines the clinical utility of Genova's stool tests, giving you the insights you need to make informed decisions and get better results for your patients. Today on The Lab Report: 4:55 Stool testing - High-level why’s 8:00 Clinical guide to basic gut function 11:00 Inflammation biomarker overload 13:30 Measuring maldigestion/malabsorption 16:15 Gut metabolites – direct vs. Next-Gen Sequencing 20:10 Infection – bacterial culture 24:45 Finding parasites Additional Resources: GI Effects Stool Profile Microbiomix Subscribe, Rate, & Review The Lab Report Thanks for tuning in to this week’s episode of The Lab Report, presented by Genova Diagnostics, with your hosts Michael Chapman and Patti Devers. If you enjoyed this episode, please hit the subscribe button and give us a rating or leave a review. Don’t forget to visit our website, like us on Facebook, follow us on Twitter, Instagram, and LinkedIn. Email Patti and Michael with your most interesting and pressing questions on functional medicine: podcast@gdx.net. And, be sure to share your favorite Lab Report episodes with your friends and colleagues on social media to help others learn more about Genova and all things related to functional medicine and specialty lab testing. To find a qualified healthcare provider to connect you with Genova testing, or to access select products directly yourself, visit Genova Connect. Disclaimer: The content and information shared in The Lab Report is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in The Lab Report represent the opinions and views of Michael Chapman and Patti Devers and their guests.See omnystudio.com/listener for privacy information.

Ready to grow your private practice? In this video, I will break down 7 clinical streams of income for mental health providers. Whether you're a therapist, psychologist, or social worker, these strategies will help you create income streams that bring more impact and freedom. WORK LESS, EARN MORE, & ENJOY LIFE TOOLS

This session focuses on various pharmacogenomics implementation models in oncology. Presenters discuss how pharmacogenomics was implemented at their respective institution, how each addressed unique barriers to implementation, and considerations for scalability, sustainability, and expansion of pharmacogenomics testing in oncology over the next 5+ years. CE for this episode expires two years after publication. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

John Murray talks football, travel & language with home nations commentators. Liam McLeod represents Scotland after their dramatic win over Greece, Mark Poyser shows up for Wales after Craig Bellamy's side lost to England, and Joel Taggart is on the pod on behalf of Northern Ireland. It's Scotland vs Northern Ireland in Clash of the Commentators and suggestions welcome for our Great Glossary of Football Commentary - WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk05:10 Favourite experiences commentating on your country 08:35 Perils of commentating off-tube 18:10 Craig Bellamy ‘puts on show' as Wales manager 23:10 Live commentaries & any countries they've not been to? 26:40 Best commentary positions in the home nations 31:25 Clash of the Commentators 36:40 Great Glossary of Football CommentaryBBC Sounds / 5 Live commentaries: Sun 12 Oct 1200 Chelsea v Tottenham in WSL, Sun 12 Oct 1430 Arsenal v Brighton & Hove in WSL, Sun 12 Oct 1700 Scotland v Belarus in WCQ, Mon 13 Oct 1945 Wales v Belgium in WCQ, Tue 14 Oct 1945 Latvia v England in WCQ, Wed 15 Oct 2000 Chelsea v Paris in UWCL.Glossary so far:DIVISION ONE Bosman, Cruyff Turn, Giving the goalkeeper the eyes, Hibs it, Onion bag, Panenka, Rabona, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep.DIVISION TWO Ball stays hit, Coat is on a shoogly peg, Daisycutter, Has that in his locker, Howler, One for the cameras, Played us off the park, Purple patch, Root and branch review, Row Z, Stramash, Taking one for the team, That's great… (football), Thunderous strike.UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Bread and butter, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Cultured/Educated left foot, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Fox in the box, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Nutmeg, Opposite number, Park the bus, PK for penalty-kick, Postage stamp, Put it in the mixer, Put their laces through it, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Roy of the Rovers stuff, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, We've got a cup tie on our hands, Winger in their pocket, Wrap foot around it, Your De Bruynes, your Gundogans etc.

What if the most overlooked organ in menopause is your skin?In this episode, Bahar speaks with Dr David Kosenko, Head of Medical and Clinical Training at Dermacosmetica, President of the Cosmetic Physicians College of Australasia, and a practising cosmetic physician with more than 30 years of clinical experience. They unpack the biological impact of oestrogen loss on the skin, why collagen declines rapidly after menopause, and how to support hormonal skin health with evidence-based care. Dr Kosenko explains MEP technology in Emepelle, a non-hormonal innovation that activates oestrogen receptors in the skin without systemic effects. The conversation also explores regenerative aesthetics, skincare routines for perimenopause and postmenopause, and the future of hormonal skin science. This episode is in partnership with Emepelle for Menopause Awareness Month.Topics covered in this episode include Menopause and skin health Oestrogen receptor function in skin Collagen loss in the first five years after menopause Adapting skincare for perimenopause and postmenopause Non-hormonal MEP technology and the innovation behind Emepelle explained Clinical results from the 20-week study How MEP in Emepelle differs from topical HRT creams Recommended skincare essentials (cleansers, antioxidants, SPF, retinoids) Regenerative aesthetics and collagen stimulation Visible improvements on neck and hands Why it is never too late to rejuvenate skin Watch the full episode here: https://youtu.be/v1sAABo2xGESee omnystudio.com/listener for privacy information.

Amy Nolan, Director of Clinical affairs, Irish Cancer Society / Lydia Whelan, diagnosed with breast cancer age 32

AI is transforming medicine at a speed never seen before. In this episode, you'll discover how digital twins and artificial intelligence will revolutionize drug discovery, eliminate human trials, and personalize your biology for longevity and high performance. Host Dave Asprey breaks down how AI can now simulate virtual cells and tissues, running clinical experiments in minutes instead of years to create truly individualized medicine. Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Dr. Derya Unutmaz is a world-renowned immunologist, systems biologist, and professor at The Jackson Laboratory. With more than 150 scientific papers, he's a leading expert in immune system research and one of the first scientists to pioneer the concept of digital twins for biology. His groundbreaking work uses AI to model how immunity, metabolism, and aging interact—creating new possibilities for personalized medicine, disease prevention, and lifespan extension. Host Dave Asprey and Dr. Unutmaz reveal how AGI will soon outperform doctors, accelerate functional medicine, and optimize human biology far beyond today's standards. You'll learn how the immune system drives inflammation and aging, how to re-engineer it for resilience, and why compounds like GLP-1 and metformin may add years to your life. You'll Learn: • How digital twins will end human drug testing • Why AGI could replace doctors and computer jobs within five years • How AI models immune function, metabolism, and aging • The role of mitochondria and inflammation in longevity • How GLP-1 drugs and metformin extend lifespan • What continuous biological monitoring means for health tracking • How AI is transforming functional medicine and personalized care • Why NAD and energy metabolism are key to human performance They explore how artificial intelligence, biohacking, and systems biology intersect to create a smarter approach to health and longevity. You'll also learn how understanding immune balance, metabolism, and mitochondrial function helps build resilience and extend your lifespan. This is essential listening for anyone serious about biohacking, hacking human performance, and extending longevity through personalized medicine, functional biology, and cutting-edge AI innovation. This is essential listening for anyone serious about biohacking, hacking human performance, improving mobility, and extending longevity. You'll also learn how neuroplasticity, metabolism, and brain optimization all connect to the way you move. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: AI medicine, Digital twins, Functional medicine, Biohacking, Longevity, Immune system, Inflammation, Personalized medicine, GLP-1 therapy, Metformin, NAD boosters, Mitochondrial function, Metabolism, AGI, Clinical trials, Human performance, Aging research, Systems biology, Immunology, Smarter Not Harder Thank you to our sponsors! BrainTap | Go to http://braintap.com/dave to get $100 off the BrainTap Power Bundle. MASA Chips | Go to https://www.masachips.com/DAVEASPREY and use code DAVEASPREY for 25% off your first order. Our Place | Head to https://fromourplace.com/ and use the code DAVE for 10% off your order. ARMRA | Go to https://tryarmra.com/ and use the code DAVE to get 15% off your first order Resources: • Keep up with Derya's work: https://x.com/derya_?lang=en • Business of Biohacking Summit | Register to attend October 20-23 in Austin, TX https://businessofbiohacking.com/ • Danger Coffee: https://dangercoffee.com/discount/dave15 • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 00:00 — Trailer 01:25 — Intro 02:26 — AI's Role in Extending Lifespan 02:56 — Regulatory Frameworks and Medical Adoption 05:19 — Problems with the Immune System 08:19 — Chronic Fatigue and Long COVID Research 10:32 — Modern Testing and Multi-Omic Analysis 14:07 — Personal Longevity Strategy and Supplements 15:17 — Understanding Exhausted Cells 23:43 — Personalization in Medicine and AI Analysis 31:35 — Longevity Escape Velocity 36:13 — AI Doctors and Prescriptions 39:55 — Data Quality Concerns in AI Training 43:19 — The Future of Wearable Technology 45:50 — Revolutionizing Education with AI 49:04 — The Future of Higher Education 52:03 — Future of Work and AI Agents See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this new episode, Rabih shares an important case with Debora, Mark, and Noah. We invite you to listen and join in on their journey as they work together to discover the final diagnosis. To join us live on Virtual Morning Report (VMR) or to present a case to us, sign up here.  Download CPSolvers App… Read More »Episode 424 – The Clinical Unknown Series with Debora, Mark, Noah and Rabih

In this episode, Dr. Sausha and Dr. Mark McCawley discuss the benefits of dental lasers in periodontal and implant dentistry. They cover laser applications in socket management, nerve regeneration, and depigmentation. The conversation highlights how lasers improve healing, disinfection, and outcomes in modern dental care.

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, is joined by Natasha Mesinkovska, MD, associate professor of Dermatology at UC Irvine, to discuss the multifaceted challenges of alopecia areata (AA), an autoimmune condition with complex comorbidities and broad psychosocial implications. The conversation begins with the stigma of hair loss and the importance of addressing the patient's emotional well-being. Dr Mesinkovska highlights her approach: asking simple but direct questions about how patients are coping and connecting them with mental health resources when needed. Comorbidities and workup are also addressed, with Dr Mesinkovska sharing her pragmatic approach to labs: thyroid-stimulating hormone test as a baseline, selective additional testing for patients with indicators of comorbidities, and requesting consultation with endocrinology when indicated. Prognosis is also discussed, with childhood onset and family history noted as adverse factors. They next explore treatment expectations, beginning with the typical timeline of response seen with oral JAK inhibitors and the importance of allowing several months for optimal hair regrowth. Many patients, once regrowth occurs, ask when they can stop therapy in hopes that results will persist without ongoing treatment; this is an important moment to counsel patients on the chronic nature of AA and emphasize that discontinuing therapy often leads to renewed hair loss. Continuing oral JAK inhibitor therapy offers the greatest likelihood of maintaining regrowth over time.  They review clinical data on the durability of response of the JAK inhibitors for AA, which has shown that relapse of hair loss is common once treatment is discontinued. For those who elect to stop therapy, it is essential to emphasize the need to resume treatment promptly at the first signs of relapse, under supervision of their dermatologist. Ongoing clinical and laboratory monitoring is also highlighted as critical to ensure long-term safety. Dr Mesinkovska then discusses differential diagnoses for AA, covering lichen planopilaris, trichotillomania, and other mimickers, with biopsy reserved for challenging cases. She next reviews the 3 approved JAK inhibitors for AA, baricitinib, ritlecitinib, and deuruxolitinib, highlighting differences in efficacy, dosing, speed of response, and the role of CYP2C9 testing specific to deuruxolitinib. Clinical study data are used to outline the features that distinguish deuruxolitinib, the newest oral JAK inhibitor, from the other agents. These include a potentially faster onset of hair regrowth, enhanced efficacy with twice-daily dosing, and the ability to identify individuals who metabolize the drug more slowly through CYP2C9 testing. Tune in to the full episode to hear how dermatologists can assess comorbidities, select systemic therapies, manage patient expectations, and support the psychosocial needs of those with AA to achieve more comprehensive care.

Recorded at the BASICS Pre-Hospital Care Conference at Sketchley Grange, this episode explores one of the most experimental tools in civilian trauma care — the abdominal aortic and junctional tourniquet. Dr Ed Barnard joins us to discuss why this device was developed, how it works, and where it might — just might — save lives when all other options have failed. The conversation traces the problem of non-compressible haemorrhage, the leading cause of potentially survivable trauma death. Conventional limb tourniquets, pelvic binders and packing can't reach these deep bleeding sites. The AAJT offers a radical alternative: external aortic compression to buy a few crucial minutes until surgical control or REBOA is possible. Ed explains the mechanism — an inflatable, ratcheted belt that can occlude the aorta or major junctional vessels — and the evidence so far. Laboratory and volunteer data show that it can stop flow, but pain and tissue ischaemia make it difficult to tolerate for long. Clinical experience remains limited to small case series, mostly in military or research settings, and no human trials yet demonstrate a survival benefit. The discussion is candid about risk and realism. The AAJT is a last-resort device, to be used only within strict governance, with clear time limits and immediate plans for definitive haemorrhage control. It's not something you reach for on a normal shift — it's something you might need once in a career, and only if every other option has failed. Ed shares insights from ongoing research, including its potential role as a bridge to REBOA, and the governance frameworks that should surround any trial use. The episode ends with a look to the future: how civilian and military collaboration might refine indications, training, and data collection for this rare but potentially life-saving intervention. Surgeon Captain Ed Barnard Surgeon Captain Ed Barnard is a Consultant in Emergency Medicine at Addenbrooke's Hospital, Cambridge, and a Professor of Emergency Medicine with the Defence Medical Services. He also serves with East Anglian Air Ambulance as a HEMS doctor (having had many years as a BASICS responder). His academic work focuses on prehospital and military trauma care, with a portfolio spanning clinical trials, blood product innovation, and trauma system development. Ed's academic work focuses on improving survival from catastrophic bleeding, particularly non-compressible and junctional haemorrhage. He has published and presented widely on trauma resuscitation, traumatic cardiac arrest, and the evolving role of devices such as the abdominal aortic and junctional tourniquet (AAJT) and REBOA. He is a co-author of the 2025 BMJ Military Health systematic review examining the utility of the AAJT-S in military practice. He is also an experienced educator, contributing to trauma training for BASICS, HEMS, and Defence Medical Services, and continues to combine clinical work with research aimed at translating lessons from military to civilian trauma care. About BASICS: The British Association for Immediate Care (BASICS) is a UK charity uniting clinicians dedicated to pre-hospital emergency medicine. Founded in 1977, it supports regional immediate-care schemes, delivers national training, and hosts the annual BASICS Pre-Hospital Care Conference, bringing together experts in trauma, retrieval, and critical care — like this conversation with Dr Ed Barnard.

As an audiologist, what do you say when a patient or client asks to receive gene therapy? The headlines are certainly grabbing public interest, but what does it mean for your practice?Clinical trials and media coverage are driving interest in this novel approach to hearing loss intervention. As our guests share, so far only one gene has received clinical trials. But patients and their families may seek this treatment or ask you questions about what it means for them.To provide background and perspective, we'll hear from two people well versed in the world of gene therapy for hearing loss: Ryan McCreery of Boys Town National Research Hospital and Jenna Devare of University of Michigan Medical School.Learn More:ASHA Voices: A Promising Outlook for Gene Therapy and Hearing LossFirst Deaf Gene Therapy Recipient in U.S. Gains HearingASHA Voices: The Limits of Our GenesASHA Voices: Audiologists Address Ototoxicity in Cancer CareTranscript

Host: Susanna Price Guest: Rudolf de Boer Want to watch that extended interview on AI in echocardiography? Go to: https://esc365.escardio.org/event/2175?resource=interview Disclaimer: ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors.  This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder Mycardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. Rudolf de Boer has declared to have potential conflicts of interest to report: the institution of Rudolf de Boer has received research grants and/or fees from Alnylam, AstraZeneca, Abbott, Bristol-Myers Squibb, NovoNordisk, and Roche; Rudolf de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, NovoNordisk, Roche, and Zoll; Rudolf de Boer received travel support from Abbott and NovoNordisk. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Clinical psychologist Annia Raja discusses her article "Why more physicians are quietly starting therapy." Annia explains how growing numbers of physicians are turning to therapy—not because they are failing, but because they are recognizing they cannot carry the weight of medicine alone. She outlines cultural shifts that are breaking down the "invincible doctor" myth, from generational openness to the impact of the pandemic, and highlights what doctors are really seeking in therapy: depth, safety, and understanding. Annia also emphasizes why quiet participation still matters, how therapy can be an investment in career longevity, and how these changes benefit both physicians and patients. Listeners will take away insights into how therapy is reshaping medical culture and why healing the healers is essential for the future of care. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

In this throwback episode, Zach and Kevin are joined by Kevin's son and expert on AI in dentistry, Charlie Fryer! Charlie discusses his master's thesis on applying Artificial Intelligence (AI) to the diagnosis of Class II caries (decay) in dentistry. Charlie, a chemical engineer with a background in data science from Georgia Tech, explains the immense, data-intensive challenges of using a deep learning model to create an objective diagnostic tool for Class II decay from bite-wing X-rays. Both hosts express an optimistic view of AI's inevitable and positive integration into dentistry as a tool to flag potential issues for the clinician's review, improving patient care and eliminating missed diagnoses. Join the Very Dental Facebook group using the password "Timmerman," Hornbrook" or "McWethy," "Papa Randy," "Lipscomb" or "Gary!" The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! -- Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code “VERYDENTAL10” you'll get another 10% off your order! Go save yourself some money and support the show all at the same time! -- The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! -- Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! -- CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!      

Today, I'm joined by Dr. Lisa Shah, Chief Medical Officer at Twin Health.   Replacing population averages with personal biomarkers, Twin Health leverages digital twin technology to address root causes of metabolic conditions like obesity and diabetes.   In this episode, we discuss how machine learning is transforming disease management.   We also cover:   Building a GLP-1 off-ramp Balancing AI with human support Achieving a 71% diabetes reversal rate   Subscribe to the podcast → insider.fitt.co/podcast  Subscribe to our newsletter → insider.fitt.co/subscribe  Follow us on LinkedIn → linkedin.com/company/fittinsider    Twin Health's Website: www.twinhealth.com  Dr. Lisa Shah's LinkedIn: https://www.linkedin.com/in/lisa-shah-4a297b19/ Twin Health's Facebook: https://www.facebook.com/twinhealthusa/ Twin Health's Instagram: https://www.instagram.com/twinhealthusa Twin Health's LinkedIn: https://www.linkedin.com/company/twinhealth/   -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com  to learn more about its smart workout solutions for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/    Chapters: (00:00) Introduction (02:00) Digital twin technology explained and healthcare applications (04:15) Why digital twin technology is finally possible now (08:30) Turning 3K daily data points into actionable guidance (11:15) Balancing digital twin AI with human care team support (15:00) Clinical outcomes and New England Journal of Medicine study (19:15) Root cause solutions vs symptom management (21:15) Scaling from employer benefits to consumer prevention (24:00) Value-based care approach vs. direct-to-consumer model (27:15) Digital twin complexity across multiple health systems (31:00) Building trust through real-time feedback loops (33:00) Agentic AI applications in healthcare delivery (37:42) Future roadmap (40:15) Conclusion  

Clinical trials are essential for improving the lives of those diagnosed with Alzheimer's disease and related dementias. With so many trials out there, it can be difficult for someone who's interested in participating in research to know where to start. Dr. Jonathan Graff-Radford joins the podcast to discuss the ins and outs of clinical trials and the state of Alzheimer's treatments today, as well as share some highlights from his presentation at the National Alzheimer's Coordinating Center's (NACC) 2025 Spring ADRC Meeting. Guest: Jonathan Graff-Radford, MD, behavioral neurologist, associate professor, vice chair, Mayo Clinic Department of Neurology, co-investigator, Mayo Clinic Alzheimer's Disease Research Center Show Notes Read more about Dr. Jonathan Graff-Radford at his profile on Mayo Clinic's website. Listen to part one and part two of our series on preclinical Alzheimer's disease and the AHEAD study with Dr. Reisa Sperling, mentioned at 19:53, on our website. Learn more about the AHEAD study on their website. Learn more about clinical trials in Wisconsin at the UW Clinical Trials Institute's website. Interested in participating in clinical trials? Visit clinicaltrials.gov or Alzheimer's Association's TrialMatch to learn how to get involved. Learn more and register for the 2025 Fall Community Conversation: Addressing Hearing Loss for Better Brain Health on our website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.

Alex got her degree from the University of Notre Dame in 2022 after finishing her dissertation on the variation in brown adipose tissue thermogenesis and its effects on metabolic health markers in adults from Samoa. She is currently a postdoctoral fellow at Pennington Biomedical Research Center working on the Military Health and Nutrition Examinations Study (MHANES) (PI: Dr. Claire Berryman). In collaboration with the US Army Research Institute of Environmental Medicine, her work with MHANES examines how the interactions between environmental (i.e. temperature, altitude), behavioral (i.e. physical activity, nutrition, sleep), and physiological (i.e. body composition, energy expenditure, metabolic health markers) factors affect health and performance in active-duty service members. She frequently collaborate with colleagues on anthropological research projects focusing on the effects of physiological adaptations/adjustments to the extremes and is passionate about bringing anthropological perspectives to clinical and military-focused research. ------------------------------ Find the paper discussed in this episode: Sarma, M. S., Niclou, A. M., & Hurd, K. J. (2025). Methodologic Opportunities for Space Health Research: Integrating Biological Anthropology Methods in Human Research for Precision Space Health and Medical Data. Wilderness & Environmental Medicine, 36(1_suppl), 104S-112S. https://doi.org/10.1177/10806032251349436 ------------------------------ Contact Dr. Niclou: Alexandra.Niclou@pbrc.edu ------------------------------ Contact the Sausage of Science Podcast and Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Cara Ocobock, Co-Host, Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu, Twitter:@CaraOcobock Anahi Ruderman, SoS Co-Producer, HBA Junior Fellow E-mail: aniruderman@gmail.com, Twitter: @ani_ruderman

Dr. Dobri Kiprov is a towering figure in the field of Plasmapheresis, also known as Therapeutic Plasma Exchange (TPE). When I had the chance to experience this treatment with him in San Francisco, I knew I had to ask all the questions that so many people want to.This procedure has been important for countless patients in helping with autoimmune diseases, reversing the effects of aging, and improving longevity.In this episode, Dr. Kiprov explains the science behind plasmapheresis and how it's making waves in the medical community. We talk about how this therapy works, its powerful effects on inflammation, and the surprising connection between systemic inflammation and the aging process.Join us as we discuss:The origins and evolution of plasmapheresis.Plasmapheresis helps remove harmful substances in the plasma that accelerate aging.The stunning results from human clinical studies show the rejuvenating power of plasmapheresis.How this procedure is becoming a cornerstone in treating autoimmune conditions and more.Tune in to learn about all these and also hear about my personal experience with this procedure. Key TakeawaysIntroduction (00:00)Overview of plasmapheresis and its benefits (01:33)Differences between plasmapheresis and plasma exchange (08:34)Applications and effectiveness of plasma exchange (12:48)Measuring systemic inflammation and inflammaging (16:58)Longevity medicine and health span (19:12)Clinical study on plasmapheresis and longevity (21:57)Intravenous immunoglobulin and its role (26:07)Long COVID and plasmapheresis (31:24)Parabiosis and plasmapheresis (34:35)Conclusion and practical advice (42:27)Additional Resources:✨ Global Apheresis: https://www.globalapheresis.com/✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/ ✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/ ✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/ —Dr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.

What if the clothes you wear and the sheets you sleep on could actively improve your health without you doing a thing? In this fascinating conversation, Seth Casden introduces us to a truly passive biohacking tool that's hiding in plain sight.Technology transforms ordinary fabrics into wellness tools by embedding them with micron-sized minerals that capture body heat and convert it into beneficial infrared light. This light penetrates the skin and increases local circulation, delivering more oxygen to cells and tissues. The beauty lies in its simplicity—no additional effort required, no lifestyle changes needed."We're converting heat energy into light energy," Casden explains, describing how the minerals in these fabrics absorb the 100+ watts of heat constantly emitting from our bodies and return it as infrared light. Clinical studies show this process increases tissue oxygenation by about 8% after just 90 minutes of wear.Unlike many wellness technologies that require dedicated time or effort, the fabric works invisibly throughout your day in clothing and bedding. Whether you're exercising, working, or sleeping, the technology continuously improves circulation—the fundamental mechanism behind numerous health benefits from enhanced recovery to better temperature regulation.For athletes, the technology offers particular advantages. "You wear it while competing and then after the race to recover as fast as you can," Casden shares from his own experience as a triathlete. Elite sports teams, Olympic athletes, and figures like Tom Brady have already embraced the technology for its performance benefits.Ready to try this effortless biohack? Casden recommends starting with either socks (if you're on your feet all day) or pillows (to potentially enhance sleep quality and brain health). With partners including Under Armour, KT Tape, and various bedding companies, Celliant products are increasingly accessible to anyone looking to optimize their wellness without adding complexity to their lives.Curious about this technology that works while you simply live your life? Listen now and discover why improved circulation might be the simplest path to better performance, faster recovery, and enhanced wellbeing.https://celliant.com/.   https://shopcelliant.com/Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/Complete Metabolic Heart Scan (LUFKIN20 for 20% off) https://www.innerscopic.com/Fasting Mimicking Diet (20% off) https://prolonlife.com/Lufkin At home blood testing (20% off) https://siphoxhealth.com/lufkinMimio Health (LUFKIN for 15% off) https://mimiohealth.sjv.io/c/5810114/2745519/30611 Web: https://robertlufkinmd.com/X: https://x.com/robertlufkinmdYoutube: https://www.youtube.com/robertLufkinmdInstagram: https://www.instagram.com/robertlufkinmd/LinkedIn: https://www.linkedin.com/in/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinThreads: https://www.threads.net/@robertlufkinmdFacebook: ...

Kyna Fong, Co-Founder and CEO of Elation Health, is developing AI tools that prioritize patient care and automate documentation and referrals to help alleviate physician burnout and improve the patient-provider relationship. Kyna emphasizes the critical role of interoperability in effective primary care, enabling primary care physicians to coordinate care. She also noted the recent White House initiative on interoperability, which encouraged the private sector to cooperate in data-sharing initiatives, now that AI can be used to overcome technical issues of data integration and analysis.  Kyna explains, "Clinical-first is not new for Elation. It's actually our founding product philosophy. When we first started building Elation, what we observed was that so many tools that were built for physicians to use and their electronic health records were very much oriented around billing needs and, in a lot of ways, followed a billing-first philosophy. And so we created Elation to really focus on clinical first, which means putting patient care first and foremost."   "The way that we are approaching AI is as a tool. It's a tool in our toolkit. It's a how and when we think about all the pressures and burdens on physicians, especially primary care physicians, that prevent them from being able to focus on their patients. We take each of those and think about, well, how can AI make this easier? And so there are a variety of areas where we've deployed AI to help our customers. There are the clear, fairly pervasive ones today that start with something like an ambient scribe that helps with documentation, saving multiple hours per day. It's radically transformative."  #ElationHealth #AI #MedAI #PrimaryCare #Physicians #EHR #HealthIT #DigitalHealth elationhealth.com Listen to the podcast here  

Kyna Fong, Co-Founder and CEO of Elation Health, is developing AI tools that prioritize patient care and automate documentation and referrals to help alleviate physician burnout and improve the patient-provider relationship. Kyna emphasizes the critical role of interoperability in effective primary care, enabling primary care physicians to coordinate care. She also noted the recent White House initiative on interoperability, which encouraged the private sector to cooperate in data-sharing initiatives, now that AI can be used to overcome technical issues of data integration and analysis.  Kyna explains, "Clinical-first is not new for Elation. It's actually our founding product philosophy. When we first started building Elation, what we observed was that so many tools that were built for physicians to use and their electronic health records were very much oriented around billing needs and, in a lot of ways, followed a billing-first philosophy. And so we created Elation to really focus on clinical first, which means putting patient care first and foremost."   "The way that we are approaching AI is as a tool. It's a tool in our toolkit. It's a how and when we think about all the pressures and burdens on physicians, especially primary care physicians, that prevent them from being able to focus on their patients. We take each of those and think about, well, how can AI make this easier? And so there are a variety of areas where we've deployed AI to help our customers. There are the clear, fairly pervasive ones today that start with something like an ambient scribe that helps with documentation, saving multiple hours per day. It's radically transformative."  #ElationHealth #AI #MedAI #PrimaryCare #Physicians #EHR #HealthIT #DigitalHealth elationhealth.com Download the transcript here  

In this episode of The Lifestyle Practice Podcast, Dr. Derek Williams and Dr. Steve Van de Graaff open up about the vision, planning, and mindset that allowed them to sell their practices and take extended time away with their families. They share the early influences that shaped their career goals, the numbers and strategies that made financial independence possible, and the emotional challenge of actually pulling the trigger. Whether you dream of early financial freedom or simply want more balance, this conversation offers insights on building a practice that supports your ideal lifestyle—both now and in the future. Connect with us: • Learn more about 1-on-1 coaching • Get access to TLP Academy • Suscribe to The Lifestyle Practice Podcast • Email Derek at derek@thelifestylepractice.com • Email Matt at matt@thelifestylepractice.com • Email Steve at steve@thelifestylepractice.com

Advancements and Challenges in Pediatric Mental Health ScreeningIn this episode of "The Pediatric Lounge," hosts discuss the importance and implications of mental health screening in pediatric care. Guest Dr. Jean Marconi, Senior VP of Strategic Partnerships and Business Development at Bright Line, delves into the challenges and opportunities within pediatric psychiatry. The conversation covers the implementation of mental health screenings, the necessity for proper coding for reimbursement, and the integration of mental health services in clinical practice. Dr. Marconi also emphasizes the significance of suicide prevention screenings and the role of pediatricians in early identification and intervention. The episode highlights the importance of practical tools, systemic changes, and comprehensive training in effectively managing pediatric mental health.Role Modeling Dr. Susan Sirrota ASQ-S Best Practice ASQ-S Tool Kit 00:00 Introduction to the Pediatric Lounge00:36 Welcoming Dr. Jean Marconi01:57 Dr. Marconi's New Role at Bright Line02:37 Bright Line's Hybrid Model and Services04:21 Understanding Pediatric Mental Health Policies12:22 Screening Tools and Their Importance14:52 Challenges in Pediatric Mental Health27:16 The Role of Schools and Pediatricians41:03 Handling Pediatric Emergencies41:35 Challenges in Managing Chronic Conditions42:49 Mental Health Stigma in Pediatrics43:51 Billing and Coding for Pediatric Care47:19 Developmental Screening Guidelines50:05 Implementing Mental Health Screenings58:01 Advocacy and Policy in Pediatric Care01:09:33 Concluding Thoughts and FarewellSupport the show

Comments or feedback? Send us a text!

In this episode, I answer the most common questions about The Doctor Coach School™ certification—especially the new Entrepreneur Track. I walk through who it's for, how it's structured, why sales is a core competency (on purpose), and exactly what it takes to graduate. If you've been coaching informally or you feel called to do more than your current clinical role allows, this will help you see the full picture so you can make a confident decision.What we cover: What DCS is: A 9-month professional certification (with up to 18 months to complete) that trains transformational, belief-led coaches.Two tracks:Entrepreneur Track (now enrolling): for clinicians who want a coaching business or to integrate coaching into an existing practice.Leadership & Organizational Change Track (“Intrapreneur”—coming 2026): for those who want to drive change inside institutions.Who it's for: Clinical doctors (MD/DO, DDS/DMD, DPT, PharmD, PsyD/PhD—clinical, etc.) who are:Already the “go-to” person for coaching/advice and want mastery,Restless to help people directly (without bureaucracy), and/orReady to be paid for their purpose with rigor and ethics.What makes DCS different:Belief first — you become your first client (self-regulation, nervous system safety, embodied belief).Sales is a core competency — you'll learn ethical, high-converting sales and must sign at least one real client during certification.End-to-end transformation — you'll coach a real human from decision to result (not just peer practice).Structure & timeline:Phase 1: Coaching Self (8 weeks) — pre-recorded lessons, weekly live skills labs, peer + mentor coaching, reflection.Phase 2: Client Acquisition — story-selling, The Bridge framework, ethical sales calls, sales-call surgery, feedback. Goal: sign a client.Phase 3: Client Transformation — coach your client through your program using DCS methodology with ongoing support.Pace: Most complete in ~9 months; you have up to 18 months to finish depending on your program length and start point.Time commitment (typical week): ~4–6 hours (1–2h modules, live skills lab + mindset coaching, 1–2h peer coaching/reflection; in Phase 3, that time often becomes coaching your client).Support you get: Weekly skills labs, dedicated mindset coaching, mentor coaching, sales call feedback/surgery, marketing feedback, and ongoing check-ins so you don't disappear when life gets lifey.Evaluation & graduation: Ongoing observations, reflections, mentor feedback, and a final recorded session with your real client scored against ICF-aligned competencies and our internal rubric. If you miss the mark, you'll get targeted feedback and the chance to resubmit.Links & How to ApplyApply now: thedoctorcoachschool.com/applynowAdmissions helpline: 1-844-4-DCS-HELP (1-844-432-7435) — speak with an admissions agent and get your specific questions answered.Open House (live, recurring): Tuesdays at 8:00 PM ET and Thursdays at 12:00 PM ET. Let's Connect: On Instagram On Facebook On LinkedIn On TikTok On my website

In this episode, Sarah E. Ginnetti, Chief Revenue Cycle Officer and VP of Clinical Revenue at UConn Health, discusses her top priorities, the role of AI and analytics in revenue cycle management, and how collaboration across clinical, finance, and strategy teams is shaping the future of healthcare operations.

In his weekly clinical update, Dr. Griffin with Vincent Racaniello chat about the ongoing Ebola outbreak in DRC, increases in screwworm diagnoses, a pertussis death in Mississippi before Dr. Griffin deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, monoclonal antibody therapy against RSV, where to find PEMGARDA, long COVID treatment center, where to go for answers to your long COVID questions, olfactory dysfunction following SARS-CoV-2 infection and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Ebola Disease (WHO: African Region) Mexico sees 32% jump in flesh-eating screwworm cases since August as cases move north (Reuters) Pediatric Pertussis Death Reported (Mississippi State Department of Health) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Measles (CDC: Measles Rubeola) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: cliff notes (CDC FluView) Influenza-Associated Pediatric Deaths — United States, 2024–25 Influenza Season (CDC: MMWR) ACIP Recommendations Summary (CDC: Influenza) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season(FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Nirsevimab Administration and RSV Hospitalization in the 2024-2025 Season (JAMA: Open Network) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Evidence to Recommendations Framework (EtR): RSV Vaccination in Adults Aged 50–59 years (CDC: National Center for Immunization and Respiratory Diseases) Efficacy and safety of respiratory syncytial virus vaccines (Cochrane Library) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort (JAMA: Open Network) Reaching out to US house representative Letters read on TWiV 1258 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Our China Healthcare Analyst Jack Lin discusses how China's biotech surge is reshaping healthcare, investment and innovation worldwide.Read more insights from Morgan Stanley.----- Transcript ----- Jack Lin: Welcome to Thoughts on the Market. I'm Jack Lin, from Morgan Stanley's China Healthcare Team. Today, the boom in China biotech – and how it's not just a headline for China-focused investors, but a story that touches all of us. It is Friday, October 3rd at 2pm in Hong Kong. Many people might not realize this but some of the next generation healthcare innovation is being developed far from Silicon Valley and Wall Street. The medicines you rely on, treatment plans that could shape your family's future, even investment opportunity that can grow your savings. They are all increasingly influenced by China's rapidly evolving biotech sector, which is transitioning from traditional generics manufacturing into the global innovation ecosystem. In fact, China's biotech industry is set to become a major player in the global innovation ecosystem. By 2040, we project China's originated assets could represent about a third of U.S. FDA approvals – up dramatically from just 5 percent today. And the question isn't if China's biotech will matter, but how global patients could benefit; and how consumers and investors worldwide might engage with its impact.What's driving this transformation? Three key components are driving the globalization of China originated drug innovations: cost, accessibility, and innovation quality. Lower cost in China's biotech sector enables more efficient development. Clinical trial quality is improving with regulatory pathways becoming more streamlined, promoting accessibility of China innovation for global markets. Finally, innovation in China's biotech sector is gaining momentum with more regionally developed medicines now eyeing market approval from leading overseas agencies like the U.S. FDA and EMA.This is all to say China is on track to become a key force on the global biotech stage. That said, right now we're also at a crossroads moment as geopolitical tensions between U.S. and China pose potential risks to the flow of innovation. Despite these uncertainties, we see a likely outcome of co-opetition, a blend of competition and collaboration, as global pharma grapples with the dual imperatives of innovation and resilience. Of course, this rapid evolution brings both opportunities and challenges. It's prompting stakeholders around the world to rethink their strategies and collaborations in this shifting landscape of global medical innovation. As the China biotech industry evolves, the choices made by investors, policy makers, and healthcare communities, both within China and globally, will determine the therapies of the future. It is truly a dynamic space, and we'll continue to bring you updates. Thanks for listening to our thoughts on the market. If you enjoy the show, please leave us a review, wherever you listen and share Thoughts on the Market with a friend or colleagues today.

John Murray, Ian Dennis & Ali Bruce-Ball talk football, travel & language. They hear from Thomas Tuchel after leaving Bellingham, Foden & Grealish out of his England squad. Plus, John is ‘humbled' by a commentary tattoo, and will anything join the ‘Cruyff Turn' in Division One of the Great Glossary of Football Commentary? Get your suggestions in with WhatsApp voicenotes to 08000 289 369 & emails to TCV@bbc.co.uk02:45 Ali has his car back! 06:05 Thomas Tuchel announces England squad, 13:50 Detailed beard analysis, 18:10 5 Live commentaries this weekend, 19:00 Forest fans turn on Ange Postecoglou, 21:05 Selhurst Park adorned with 5 Live quotes, 22:30 John ‘humbled' by commentary tattoo, 23:35 Can Crystal Palace win the Premier League? 26:20 Ali vs Ian in Clash of the Commentators, 33:00 The Great Glossary of Football Commentary.BBC Sounds / 5 Live Premier League commentaries: Sat 1500 Arsenal v West Ham, Sat 1500 Man Utd v Sunderland on Sports Extra, Sat 1730 Chelsea v Liverpool, Sun 1400 Newcastle v Forest, Sun 1400 Everton v Palace on Sports Extra Sun 1400 Aston Villa v Burnley on BBC Sport website & app, Sun 1400 Wolves v Brighton on BBC Sport website & app, Sun 1630 Brentford v Man City.Glossary so far:DIVISION ONE Bosman, Cruyff Turn, Onion bag, Panenka, Rabona, Where the kookaburra sleeps, Where the owl sleeps, Where the spiders sleep.DIVISION TWO Daisycutter, Howler, One for the cameras, Played us off the park, Purple patch, Root and branch review, Row Z, Taking one for the team, That's great… (football), Thunderous strike.UNSORTED 2-0 is a dangerous score, After you Claude, All-Premier League affair, Aplomb, Bag/box of tricks, Brace, Brandished, Breaking the deadlock, Bundled over the line, Champions elect / champions apparent, Clinical finish, Commentator's curse, Coupon buster, Cultured/Educated left foot, Denied by the woodwork, Draught excluder, Elimination line, Fellow countryman, Foot race, Formerly of this parish, Fox in the box, Free hit, Goalkeepers' Union, Goalmouth scramble, Good touch for a big man, Honeymoon Period, In and around, In the shop window, Keeping ball under their spell, Keystone Cops defending, Languishing, Loitering with intent, Marching orders, Nestle in the bottom corner, Numbered derbies, Nutmeg, Opposite number, Park the bus, PK for penalty-kick, Postage stamp, Put it in the mixer, Put their laces through it, Rasping shot, Red wine not white wine, Relegation six-pointer, Rooted at the bottom, Route One, Roy of the Rovers stuff, Sending the goalkeeper the wrong way, Shooting boots, Sleeping giants, Slide rule pass, Small matter of, Spiders web, Stayed hit, Steepling, Stinging the palms, Stonewall penalty, Straight off the training ground, Stramash, Taking one for the team, Team that likes to play football, Throw their cap on it, Thruppenny bit head / 50p head, Towering header, Two good feet, Turning into a basketball match, Turning into a cricket score, Usher/Shepherd the ball out of play, Walking a disciplinary tightrope, Wand of a left foot, We've got a cup tie on our hands, Winger in their pocket, Wrap foot around it, Your De Bruynes, your Gundogans etc.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sanofi lowers prices, oral pill for T1D prevention studied, updates from Medtronic, Tandem, and Sequel Med Tech, falsely lower A1Cs (and why that happens), Biolinq gets FDA okay for micro-needle CGM and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX French drugmaker Sanofi says it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status. The program, originally meant for uninsured diabetes patients, would now include those with commercial insurance or Medicare, the drugmaker said. Patients will be able to purchase any combination, type, and quantity of Sanofi insulins with a valid prescription for the fixed monthly price of $35, starting January 1. Lilly and Novo also have similar programs through which they offer insulin products for $35 a month for U.S. patients regardless of whether the patients have insurance. There is no law at work here – the only legislation that has changed the price of insulin came with the Inflation Reduction Act in 2022 with the Medicare cap. Helping lower the cost here, biosimilars hitting the market and the huge profitability for GLP-1 drugs for Novo and Lilly https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-offer-all-insulin-products-35-per-month-us-2025-09-26/ XX A pill typically prescribed for rheumatoid arthritis and alopecia might help slow the progression of type 1 diabetes, a new study says. Baricitinib (bare-uh-SIT-nib) safely preserved the body's own insulin production in people newly diagnosed with type 1 diabetes.. and their diabetes started progressing once they stopped taking baricitinib, results show. They produced less insulin and had less stable blood sugar levels.   Baricitinib works by quelling signals in the body that spur on the immune system, and is already approved for treating autoimmune conditions such as rheumatoid arthritis, ulcerative colitis and alopecia, researchers said.   “Among the promising agents shown to preserve beta cell function in type 1 diabetes, baricitinib stands out because it can be taken orally, is well tolerated, including by young children, and is clearly efficacious,” Waibel said. “We are hopeful that larger phase III trials with baricitinib are going to commence soon, in people with recently diagnosed type 1 diabetes as well as in earlier stages to delay insulin dependence,” she added. “If these trials are successful, the drug could be approved for type 1 diabetes treatment within five years.”   Findings presented at medical meetings should be considered preliminary until published in a peer-reviewed journal.   https://www.usnews.com/news/health-news/articles/2025-09-23/pill-effective-in-slowing-type-1-diabetes-progression XX An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease after diagnosis. The Drug, called ATG, is currently used together with other medicines to prevent and treat the body from rejecting a kidney transplant. It can also be used to treat rejection following transplantation of other organs, such as hearts, gastrointestinal organs, or lungs. The researchers studied 117 people aged five to 25, who'd been diagnosed with type 1 diabetes within the past three to nine weeks. The participants were from 14 centers across eight European countries and were randomized to be given different doses of ATG (0.1, 0.5, 1.5, or 2.5 mg/kg) or a placebo. ATG was given as a two-day intravenous (IV) infusion. The main goal was to see how well the pancreas could still make insulin after 12 months, measured by C-peptide levels during a special meal test. C-peptide is released into the blood along with insulin by the pancreas.   The findings are promising, showing that ATG, even at a relatively low dose, can slow the loss of insulin-producing cells in young people newly diagnosed with type 1 diabetes. The lower dose also caused fewer side effects, making it a more practical option. https://newatlas.com/disease/antithymocyte-globulin-newly-diagnosed-type-1-diabetes/     XX The FDA has delayed its feedback on Lexicon Pharmaceuticals' application to bring Zynquista (sotagliflozin) to people with type 1 diabetes. The agency had planned to respond this month but will now wait until the fourth quarter after reviewing new data from ongoing studies. Zynquista, an oral drug meant to be used with insulin, has already been approved for heart failure (marketed as Inpefa). But in type 1 diabetes, it faces safety concerns: last year an FDA advisory committee voted 11–3 that its benefits don't outweigh the increased risk of diabetic ketoacidosis (DKA). The FDA later issued a complete response letter rejecting the drug. Lexicon is still pushing forward, hoping its additional submissions will strengthen Zynquista's case for type 1 diabetes approval. https://www.biospace.com/fda/after-fda-rejection-lexicons-type-1-diabetes-drug-hit-with-another-regulatory-delay     XX A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk of serious complications for thousands of Black and South Asian men in the UK—and potentially millions worldwide. A new study found around one in seven Black and one in 63 South Asian men in the UK carry a genetic variant known as G6PD deficiency. Men with G6PD deficiency are, on average, diagnosed with type 2 diabetes four years later than those without the gene variant. But despite this, fewer than one in 50 have been diagnosed with the condition.   G6PD deficiency does not cause diabetes, but it makes the widely used HbA1c blood test—which diagnoses and monitors diabetes—appear artificially low. This can mislead doctors and patients, resulting in delayed diabetes diagnosis and treatment.   The study found men with G6PD deficiency are at a 37% higher risk of developing diabetes-related microvascular complications, such as eye, kidney, and nerve damage, compared to other men with diabetes.   "This study highlights important evidence that must be used to tackle these health inequalities and improve outcomes for Black communities. Preventative measures are now needed to ensure that Black people, especially men, are not underdiagnosed or diagnosed too late." https://medicalxpress.com/news/2025-09-hidden-genetic-delay-diabetes-diagnosis.html XX Novo Nordisk today announced the resubmission of its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Awiqli® (insulin icodec) injection, a once-weekly basal insulin treatment for adults living with type 2 diabetes. If approved, Awiqli® would become the first once-weekly basal insulin available in the United States, providing an alternative to daily basal insulin injections for adults living with type 2 diabetes.   The resubmission is based on results from the ONWARDS type 2 diabetes phase 3a program for once-weekly Awiqli® which is comprised of five randomized, active-controlled, treat-to-target clinical trials in approximately 4,000 adults with type 2 diabetes. The clinical program evaluated Awiqli® vs. daily basal insulin and the primary endpoint in these trials was change in A1C from baseline.1-5 Awiqli® is approved in the EU, along with 12 additional countries. In addition, regulatory filings have been completed in several other countries, with further regulatory decisions expected in 2025. XX Interesting news from Sequel Med Tech – they've signed an agreement with Arecor to pair the twiist pump with AT278 an ultra-concentrated (500U/mL), ultra-rapid insulin in development. They also have a deal with Medtronic to develop insulin for new pumps. This insulin isn't yet approved, it's 5 times stronger than standard fast acting  it's hoped that a clinical study will begin next year. Arecor says its insulin could potentially be the only option capable of enabling and catalyzing the next generation of longer-wear and miniaturized automated insulin delivery systems.   https://www.drugdeliverybusiness.com/sequel-arecor-develop-rapid-insulin-twiist/ XX Tandem Diabetes Care announes its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and Company's Lyumjev® (insulin lispro-aabc injection) ultra-rapid acting insulin in the United States (U.S.).   – The t:slim X2 insulin pump with Control-IQ+ technology is now cleared for use with Lyumjev for people with type 1 diabetes ages 2 and above and all adults with type 2 diabetes. The companies are continuing to work toward securing Lyumjev compatibility for the Tandem Mobi pump. https://hitconsultant.net/2025/09/29/tandem-diabetes-cares-tslim-x2-pump-cleared-for-use-with-lillys-ultra-rapid-lyumjev-insulin/ XX You can now place your order for the MiniMed™ 780G system with the Instinct sensor, made by Abbott. And if you are already a MiniMed 780G user, you can place an upgrade order today. ​This is a 15 day wear sensor, with no transmitter or overtape required. It looks the same at other Abbot sensors such as the Libre but is proprietary to Medtronic. Shipments are scheduled to start in November.   ​ https://www.drugdeliverybusiness.com/medtronic-launches-minimed-780g-instinct-abbott/   XX The global type 1 diabetes (T1D) burden continues to increase rapidly driven by rising cases, ageing populations, improved diagnosis and falling death rates. ,   The study estimates that T1D will affect 9.5 million people globally in 2025 (up by 13% since 2021), and this number is predicted to rise to 14.7 million in 2040. However, due to lack of diagnosis and challenges in collecting sufficient data, the actual number of individuals living with T1D is likely much higher, researchers say.   In fact, they estimate that there are an additional 4.1 million 'missing people' who would have been alive in 2025 if they hadn't died prematurely from poor T1D care, including an estimated 669,000 who were not diagnosed. This is particularly true in India, where an estimated 159,000 people thought to have died from missed diagnoses. The study predicts that 513,000 new cases of T1D will be diagnosed worldwide in 2025, of which 43% (222,000) will be people younger than 20 years old. Finland is projected to have the highest incidence of T1D in children aged 0-14 years in 2025 at around 64 cases per 100,000. The substantial increases in T1D forecasts between 2025 and 2040 underscore the urgent need for action. As co-author Renza Scibilia from Breakthrough T1D explains, "Early diagnosis, access to insulin and diabetes supplies, and proper healthcare can bring enormous benefits, with the potential to save millions of lives in the coming decades by ensuring universal access to insulin and improving the rate of diagnosis in all countries."   The authors note some important limitations to their estimates, including that while the analysis uses the best available data, predictions are constrained by the lack of accurate data in most countries-highlighting the urgent need for increased surveillance and research. They also note that data on misdiagnosis and adult populations remain limited, and the analysis assumes constant age-specific incidence and mortality over time. Furthermore, incidence data from the COVID-19 period were excluded from part of the modelling to avoid bias. Future updates are expected to improve as new data become available and applied. https://www.news-medical.net/news/20250919/New-study-warns-of-millions-of-undiagnosed-and-missing-people-with-type-1-diabetes.aspx XX A new study has found that semaglutide — the active ingredient found in some GLP-1 medications prescribed for diabetes and to aid weight loss — may help protect the eyes from diabetic retinopathy. Researchers estimate that as much as 40% of all people with diabetes also have diabetic retinopathy — a potentially blinding eye condition caused by blood vessel damage in the eye's retina. There is currently no cure for diabetic retinopathy. The condition is often managed through injections of anti-VEGF medications into the eye, surgery, and blood sugar monitoring and control. For this lab-based study, researchers used samples of human retinal endothelial cells that were treated with different concentrations of semaglutide. The cells were then placed in a solution with both a high glucose level and high level of oxidative stress — where there is an imbalance of antioxidants and free radicals — for 24 hours.   Past studies show that oxidative stress plays a role in the formation of diabetic retinopathy.   At the study's conclusion, researchers found that the retinal cells treated with semaglutide were twice as likely to survive than cells that were untreated. Additionally, the treated cells were found to have larger stores of energy.   Scientists also found that three markers of diabetic retinopathy were decreased in the semaglutide-treated retinal cells. First, the levels of apoptosis — a form of cell death — decreased from about 50% in untreated cells to about 10% in semaglutide-treated cells. The production of the free radical mitochondrial superoxide decreased from about 90% to about 10% in the treated retinal cells.   Researchers also found the amount of advanced glycation end-products — harmful compounds that can collect in people with diabetes and are known to cause oxidative stress — also decreased substantially.   Lastly, scientists reported that the genes involved in the production of antioxidants were more active in the semaglutide-treated cells when compared to untreated cells. Researchers believe this is a sign that semaglutide may help repair damage to the retinal cells.   “Our study did not find that these drugs harmed the retinal cells in any way — instead, it suggests that GLP1-receptor agonists protect against diabetic retinopathy, particularly in the early stages,” Ioanna Anastasiou, PhD, molecular biologist and postdoctoral researcher at the National and Kapodistrian University in Greece, and lead author of this study, said in a press release.   “Excitingly, these drugs may be able to repair damage that has already been done and so improve sight. Clinical trials are now needed to confirm these protective effects in patients and explore whether GLP-1 receptor agonists can slow, or even halt, the progression of this vision-robbing condition.” https://www.medicalnewstoday.com/articles/ozempic-semaglutide-may-help-protect-against-diabetes-related-blindness-retinopathy   XX Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. This one is tricky – it's called a needle free CGM but it also says it uses micro needles. By the way, De Novo isn't exactly the same as what we think of for FDA approval for medical devices. It's not as rigorous but it's a streamlined route for novel, low to moderate risk devices with no existing equivalent. We'll see how this one turns out. https://www.hmenews.com/article/biolinq-s-multi-function-biosensor-receives-fda-de-novo-classification

Join the Behind the Knife Surgical Oncology Team as we discuss the nuances in the work up and management of patients with pheochromocytomas. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center. Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles. Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 2ndYear Surgical Oncology fellow at MD Anderson. Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a General Surgery physician in the United States Air Force station at RAF Lakenheath. Joe (Joseph) Broderick, MD, MA (@joebrod5) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Galen Gist, MD (@gistgalen) is a General Surgery research resident between his second and third year at Brooke Army Medical Center. Learning Objectives: 1)    Review the presentation of patients with pheochromocytomas.  2)    Review the work up of patients with pheochromocytomas.  3)    Review the treatment of patients with pheochromocytomas.  4)    Review the surveillance of patients with pheochromocytomas.  References used in the making of this episode: Patel D. Surgical approach to patients with pheochromocytoma. Gland Surg. 2020;9(1):32-42. doi:10.21037/gs.2019.10.20. PMID: 32206597; PMCID:PMC7082266.   Eisenhofer G, Lenders JW, Siegert G, et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48(11):1739-1749. doi:10.1016/j.ejca.2011.07.016. PMID:22036874; PMCID: PMC3372624.   Lenders JWM, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665-675. doi:10.1016/S0140-6736(05)67139-5.   Vicha A, Musil Z, Pacak K. Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options. Curr Opin Endocrinol Diabetes Obes. 2013;20(3):186-191. doi:10.1097/MED.0b013e32835fcc45. PMID: 23481210; PMCID: PMC4711348. https://pubmed.ncbi.nlm.nih.gov/23481210/ Dickson PV, Alex GC, Grubbs EG, et al. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011;150(3):452-458. doi:10.1016/j.surg.2011.07.004. https://pubmed.ncbi.nlm.nih.gov/21878230/ Lei K, Wang X, Yang Z, et al. Comparison of the retroperitoneal laparoscopic adrenalectomy versus transperitoneal laparoscopic adrenalectomy for large (≥6 cm) pheochromocytomas: a single-centre retrospective study. Front Oncol. 2023;13:1043753. doi:10.3389/fonc.2023.1043753. PMID: 36910608; PMCID: PMC9992891. https://pubmed.ncbi.nlm.nih.gov/36910608/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

ADHD affects more than 7 million children in the U.S., with many experiencing moderate to severe symptoms; yet nearly a third receive no treatment, highlighting the need for broader, integrative solutions Research shows children with ADHD are more likely to have magnesium deficiency, which disrupts neurotransmitters, stress response, and brain signaling. This worsens hyperactivity, impulsivity, inattention, and emotional instability Clinical trials demonstrate magnesium supplementation improves behavior, focus, and social interactions in children with ADHD, with the strongest benefits observed in those correcting underlying magnesium deficiencies Food alone is often not enough to restore optimal magnesium levels due to soil depletion and poor absorption. Supplementation with forms like glycinate, malate, or L-threonate is a valuable tool Environmental and lifestyle strategies, like reducing pesticide and chemical exposure and improving gut health, help manage or reduce ADHD symptoms naturally

Kaylin and Sharmin were joined by UCLA Cardiology fellows, Drs. Rachel Ohman and Angela Duvalyan, to discuss a case of a 49 year old woman with acute chest pain. Angela Duvalyan, MD is a second year Cardiology Fellow at University of California, Los Angeles (UCLA). Her clinical interests include interventional cardiology, medical education, and clinical… Read More »Episode 422: WDx #38: Clinical Unknown with UCLA Cardiology fellows

So many PAs reach out to me asking about how to transition from a clinical career to non-clinical. There are lots of options and pathways out there, and today I'm excited to have my dear friend, Courtney Titus, share her story of creating her own non-clinical career. Courtney is a Pediatric ER PA turned Director of a Pediatric Clinical Pathways program that she built herself! Tune into today's episode as Courtney shares the nitty gritty on how she created a non-clinical career. She keeps it real by sharing both the good and the bad of building her current role. Stay tuned to the end of the episode where Courtney shares actionable tips on how other PAs can also move into non-clinical careers. My biggest takeaway from today's conversation with Courtney - follow the path of joy. What brings you joy and fulfillment, both personally and professionally? Get crystal clear on that vision and then you can create your own pathway to achieve that joy.SPONSORS

Send us a textWill Van Derveer, MD is a leader in the adoption of integrative psychiatry practices globally. After discovering that his conventional psychiatric training was inadequate to answer many of the challenges facing his patients, Dr. Van Derveer began to learn how to resolve the root causes of common psychiatric problems such as depression, anxiety, and insomnia.

From ancient Sumerian epics to modern-day sightings in England's Cannock Chase, the werewolf has terrorized humanity for over 2,000 years — and the real history includes medieval trials that tortured and executed thousands of accused shapeshifters, medical conditions that spawned the legends, and 35 documented sightings in a single forest that continue to this day. Journey through the dark truth behind lycanthropy, from the She-Wolves of Jülich who allegedly killed 94 people to the shocking werewolf trials that made witch hunts look merciful, and discover why every culture on Earth has its own terrifying version of the wolf-human hybrid.Join the DARKNESS SYNDICATE for the ad-free version: https://weirddarkness.com/syndicateTake the WEIRD DARKNESS LISTENER SURVEY and help mold the future of the podcast: https://weirddarkness.com/surveyIN THIS EPISODE: The idea of the werewolf has been with us for a long time – the first mention of a werewolf that we know of is over two thousand years ago. We'll look at the origins of the werewolf, look at whether they are actually real, and if so, how one goes about becoming one, and some of the cures believed to release the man from the beast. Of course, it's not always the Wolf-Man… sometimes it's the Wolf-Woman. We'll look at the most fearsome lady werewolves throughout history! I'll tell you about the trials and punishments of those convicted of being werewolves – many probably wish they'd have confessed to being witches instead! Plus, what if I was to tell you that werewolves truly ARE real – and that a small village has been terrorized by them for decades – right up to modern day? There is convincing evidence to back up my claim! All of this and more werewolfism can be found in this episode!CHAPTERS & TIME STAMPS (All Times Approximate)…00:00:00.000 = Lead-In00:02:57.556 = Show Intro00:04:50.336 = Ancient Origins of Werewolves00:26:04.006 = Who's Afraid of Virginia Werewolf?00:35:55.899 = The Werewolf Trials00:48:53.940 = The Lycanthrope Metaphor00:54:10.432 = Lycans of Cannock Chase01:02:35.974 = Little-Known Lycan Lore01:05:35.605 = Show CloseSOURCES AND RESOURCES FROM THE EPISODE…BOOK: “Giants, Monsters and Dragons” by Carol Rose: https://amzn.to/36k0VW0BOOK: “The Werewolf Delusion” by Ian Woodward: https://amzn.to/2Sa74LVBOOK: “The Book of Werewolves” by Reverend Sabine Baring-Gould: https://amzn.to/3jgTLp5EPISODE: “The Werewolf Panic of the 1970's”: https://weirddarkness.tiny.us/48s5bbkk EPISODE: “Werewolves of Central England”: https://weirddarkness.tiny.us/2vpt52rn EPISODE: “Werewolf In The Bronx”: https://weirddarkness.tiny.us/y3auryjk EPISODE: “A Summer of Werewolves”: https://weirddarkness.tiny.us/2p875ynn EPISODE: “Planet Werewolf”: https://weirddarkness.tiny.us/yb6ck67a EPISODE: “The Beast Of The Land Between The Lakes”: https://weirddarkness.tiny.us/5n8jcczz EPISODE: “The Beast of Barmston Drain”: https://weirddarkness.tiny.us/mrs9j8xu EPISODE: “The Ohio Dogman”: https://weirddarkness.tiny.us/2p8rc5su EPISODE: “The Skinwalker Ranch, Home To Real Werewolves”: https://weirddarkness.tiny.us/2p975j56 EPISODE: “Hairy Humanoids of Texas”: https://weirddarkness.tiny.us/yckkfhun EPISODE: “Skinwalkers and Shapeshifters”: https://weirddarkness.tiny.us/mr2w57xr VIDEO: “A Brief History of Horror – Werewolves”: https://www.youtube.com/watch?v=tBLcGH1MpRgVIDEO: “Legends of the Werewolves”: https://www.youtube.com/watch?v=HCHZjU7Hi0w“The Origins and Lore of Werewolves” from History Daily: https://tinyurl.com/y4l7ytmk, Tanika Koosmen for The Conversation: https://tinyurl.com/y5jy9uog, Benjamin Radford for Live Science: https://tinyurl.com/yclcqmqp, and Ella Talkin for Ranker: https://tinyurl.com/yy55wq9q“The Werewolf Trials” by Inigo Gonzalez for Ranker: https://tinyurl.com/y2qmp4n2“The Lycans of Cannock Chase” by Hugh Landman for Ranker: https://tinyurl.com/s6h83am“Who's Afraid of Virginia Werewolf?” by April A Taylor for Ranker: https://tinyurl.com/y3qz82on“How Werewolves Work” by Tracy V.V. Wilson for How Stuff Works: https://tinyurl.com/y3oe9bte“Little-Known Lycan Lore” by Jonathan Gordon for History Answers: https://tinyurl.com/y3jb5scq=====(Over time links may become invalid, disappear, or have different content. I always make sure to give authors credit for the material I use whenever possible. If I somehow overlooked doing so for a story, or if a credit is incorrect, please let me know and I will rectify it in these show notes immediately. Some links included above may benefit me financially through qualifying purchases.)= = = = ="I have come into the world as a light, so that no one who believes in me should stay in darkness." — John 12:46= = = = =WeirdDarkness® is a registered trademark. Copyright ©2025, Weird Darkness.=====Originally aired: September 30, 2020EPISODE PAGE at WeirdDarkness.com (includes list of sources): https://weirddarkness.com/werewolvesABOUT WEIRD DARKNESS: Weird Darkness is a true crime and paranormal podcast narrated by professional award-winning voice actor, Darren Marlar. Seven days per week, Weird Darkness focuses on all thing strange and macabre such as haunted locations, unsolved mysteries, true ghost stories, supernatural manifestations, urban legends, unsolved or cold case murders, conspiracy theories, and more. On Thursdays, this scary stories podcast features horror fiction along with the occasional creepypasta. Weird Darkness has been named one of the “Best 20 Storytellers in Podcasting” by Podcast Business Journal. Listeners have described the show as a cross between “Coast to Coast” with Art Bell, “The Twilight Zone” with Rod Serling, “Unsolved Mysteries” with Robert Stack, and “In Search Of” with Leonard Nimoy.DISCLAIMER: Ads heard during the podcast that are not in my voice are placed by third party agencies outside of my control and should not imply an endorsement by Weird Darkness or myself. *** Stories and content in Weird Darkness can be disturbing for some listeners and intended for mature audiences only. Parental discretion is strongly advised.#Werewolves #TrueCrime #Paranormal #MedievalHistory #Cryptozoology